Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortInjection that cuts LDL cholesterol by about 60%.Cholesterol injection given twice a year.
Body systemHeart & CholesterolHeart & Cholesterol
Drug classPCSK9 inhibitorsPCSK9 inhibitors
SupplyPrescription onlyPrescription only
Main usesHigh LDL cholesterol despite statins, Familial hypercholesterolaemia, Established cardiovascular diseaseHigh LDL cholesterol despite statins, Familial hypercholesterolaemia
How it worksStops a protein from destroying the liver's cholesterol 'catchers'.Switches off the liver's instructions to make PCSK9.
Starts working——
Half-life11–17 days—
Typical adult dose140 mg every 2 weeks or 420 mg once a month under the skin.284 mg under the skin at day 0, at 3 months, then every 6 months.
FormsPre-filled pen injectionPre-filled syringe
Common side effectsInjection-site reactions, Cold-like symptoms, Back painInjection-site reactions, Joint pain
Serious side effectsAllergic reactions (rare)None common in trials
Don't take if——
Alcohol——
PregnancyUse with cautionAntibodies cross the placenta later in pregnancy; limited data.Use with cautionNot recommended; no data.
Breastfeeding——
In use since20152020
Brand namesUnited States: RepathaUnited Kingdom: RepathaIndia: RepathaUnited States: LeqvioUnited Kingdom: LeqvioIndia: Sybrava
Legal status——
ATC codeC10AX13C10AX16

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker